Evaluation of recombinant bovine somatotropin in the treatment of ovine pregnancy toxaemia.
Forty multigravid ewes with naturally-occurring ovine pregnancy toxaemia were treated with a concentrated oral dextrose and electrolyte solution administered three times daily an oral and a single subcutaneous injection of either a slow release formulation of 160mg recombinant bovine somatotropin (n = 17) or placebo injection (n = 23). A higher recovery rate was achieved in ewes treated with 160mg recombinant bovine somatotropin compared with controls (58.8 versus 34.8%, respectively), and more lambs were born alive and survived to 24th from treated ewes (15 of 46 lambs; 32.6%) compared with control ewes (12 of 62 lambs; 19.4%) but the treatment effects were not significantly different from the control group (P > 0.05).